[go: up one dir, main page]

ITMI962408A0 - Nuovo uso della creatina - Google Patents

Nuovo uso della creatina

Info

Publication number
ITMI962408A0
ITMI962408A0 IT96MI002408A ITMI962408A ITMI962408A0 IT MI962408 A0 ITMI962408 A0 IT MI962408A0 IT 96MI002408 A IT96MI002408 A IT 96MI002408A IT MI962408 A ITMI962408 A IT MI962408A IT MI962408 A0 ITMI962408 A0 IT MI962408A0
Authority
IT
Italy
Prior art keywords
creatine
new use
new
Prior art date
Application number
IT96MI002408A
Other languages
English (en)
Inventor
Marco Anelli
Ettore Strumia
Original Assignee
Monsanto It Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11375243&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ITMI962408(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Monsanto It Spa filed Critical Monsanto It Spa
Priority to IT96MI002408A priority Critical patent/IT1298420B1/it
Publication of ITMI962408A0 publication Critical patent/ITMI962408A0/it
Priority to PT97951157T priority patent/PT941081E/pt
Priority to DE69718506T priority patent/DE69718506T2/de
Priority to EP97951157A priority patent/EP0941081B1/en
Priority to CN97199783A priority patent/CN1237904A/zh
Priority to CNA200410079798XA priority patent/CN1623534A/zh
Priority to RU99112945/14A priority patent/RU2202345C2/ru
Priority to BR9713514-3A priority patent/BR9713514A/pt
Priority to DK97951157T priority patent/DK0941081T3/da
Priority to AT97951157T priority patent/ATE230983T1/de
Priority to ES97951157T priority patent/ES2191206T3/es
Priority to US09/284,465 priority patent/US6242490B1/en
Priority to PCT/EP1997/006225 priority patent/WO1998022099A2/en
Priority to ARP970105291A priority patent/AR009425A1/es
Publication of ITMI962408A1 publication Critical patent/ITMI962408A1/it
Publication of IT1298420B1 publication Critical patent/IT1298420B1/it
Application granted granted Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IT96MI002408A 1996-11-19 1996-11-19 Uso della creatina nell'insufficienza cardio-respiratoria IT1298420B1 (it)

Priority Applications (14)

Application Number Priority Date Filing Date Title
IT96MI002408A IT1298420B1 (it) 1996-11-19 1996-11-19 Uso della creatina nell'insufficienza cardio-respiratoria
PCT/EP1997/006225 WO1998022099A2 (en) 1996-11-19 1997-11-10 New use of creatine
BR9713514-3A BR9713514A (pt) 1996-11-19 1997-11-10 Novo uso de creatina
DK97951157T DK0941081T3 (da) 1996-11-19 1997-11-10 Ny anvendelse af creatin
EP97951157A EP0941081B1 (en) 1996-11-19 1997-11-10 New use of creatine
CN97199783A CN1237904A (zh) 1996-11-19 1997-11-10 肌酸的新用途
CNA200410079798XA CN1623534A (zh) 1996-11-19 1997-11-10 肌酸的新用途
RU99112945/14A RU2202345C2 (ru) 1996-11-19 1997-11-10 Новое применение креатина
PT97951157T PT941081E (pt) 1996-11-19 1997-11-10 Nova utilizacao de creatina
DE69718506T DE69718506T2 (de) 1996-11-19 1997-11-10 Neue verwendung von kreatin
AT97951157T ATE230983T1 (de) 1996-11-19 1997-11-10 Neue verwendung von kreatin
ES97951157T ES2191206T3 (es) 1996-11-19 1997-11-10 Nueva utilizacion de la creatina.
US09/284,465 US6242490B1 (en) 1996-11-19 1997-11-10 Use of creatine
ARP970105291A AR009425A1 (es) 1996-11-19 1997-11-13 Uso de creatina en la preparacion de un farmaco para el tratamiento de insuficiencias cardiacas y/o respiratorias

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT96MI002408A IT1298420B1 (it) 1996-11-19 1996-11-19 Uso della creatina nell'insufficienza cardio-respiratoria

Publications (3)

Publication Number Publication Date
ITMI962408A0 true ITMI962408A0 (it) 1996-11-19
ITMI962408A1 ITMI962408A1 (it) 1998-05-19
IT1298420B1 IT1298420B1 (it) 2000-01-05

Family

ID=11375243

Family Applications (1)

Application Number Title Priority Date Filing Date
IT96MI002408A IT1298420B1 (it) 1996-11-19 1996-11-19 Uso della creatina nell'insufficienza cardio-respiratoria

Country Status (13)

Country Link
US (1) US6242490B1 (it)
EP (1) EP0941081B1 (it)
CN (2) CN1237904A (it)
AR (1) AR009425A1 (it)
AT (1) ATE230983T1 (it)
BR (1) BR9713514A (it)
DE (1) DE69718506T2 (it)
DK (1) DK0941081T3 (it)
ES (1) ES2191206T3 (it)
IT (1) IT1298420B1 (it)
PT (1) PT941081E (it)
RU (1) RU2202345C2 (it)
WO (1) WO1998022099A2 (it)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3384539B2 (ja) * 1997-09-05 2003-03-10 義之 内田 喘息治療剤
EP1051914A1 (de) * 1999-05-08 2000-11-15 DSM Fine Chemicals Austria GmbH Verwendung von Kreatin als Futterzusatz
US20030212136A1 (en) * 2001-09-14 2003-11-13 Vennerstrom Jonathan L. Creatine ester pronutrient compounds and formulations
US9833427B2 (en) * 2000-09-14 2017-12-05 Board Of Regents Of The University Of Nebraska Creatine ester anti-inflammatory compounds and formulations
US20030212130A1 (en) * 2000-09-14 2003-11-13 Miller Donald W. Creatine ester anti-inflammatory compounds and formulations
US20040013732A1 (en) * 2001-09-25 2004-01-22 Michael Farber Starch-based delivery system for creatine
US20080160086A1 (en) * 2004-02-19 2008-07-03 Scepter Holdings, Inc. Delivery Systems For Calcium
US20060025475A1 (en) * 2004-07-29 2006-02-02 Stanley Antosh Use of methyl pyruvate for the purpose of increasing muscle energy production.
US20060052448A1 (en) * 2004-09-04 2006-03-09 Mr. Stanley Antosh Use of methyl pyruvate or methyl pyruvic acid for the treatment of diseases of the nervous system and for protecting a human central nervous system against neuronal degeneration caused by defective intracellular energy production.

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2244534B1 (it) * 1973-06-27 1977-07-01 Biotherax Lab
US4783530A (en) * 1986-11-13 1988-11-08 Marion Laboratories, Inc. 8-arylxanthines
US5470838A (en) * 1987-10-28 1995-11-28 Pro-Neuron, Inc. Method of delivering exogenous uridine or cytidine using acylated uridine or cytidine
GB9215746D0 (en) * 1992-07-24 1992-09-09 Hultman Eric A method of increasing creatine supply depot
AU3086897A (en) * 1996-06-28 1998-01-21 Ipr-Institute For Pharmaceutical Research Ag Drug preparations, containing creatine with at least one salt of calcium, magnesium, manganese or zinc

Also Published As

Publication number Publication date
IT1298420B1 (it) 2000-01-05
US6242490B1 (en) 2001-06-05
PT941081E (pt) 2003-04-30
RU2202345C2 (ru) 2003-04-20
ES2191206T3 (es) 2003-09-01
DE69718506T2 (de) 2003-07-31
BR9713514A (pt) 2000-02-29
WO1998022099A2 (en) 1998-05-28
ITMI962408A1 (it) 1998-05-19
EP0941081A2 (en) 1999-09-15
EP0941081B1 (en) 2003-01-15
WO1998022099A3 (en) 1998-07-09
CN1623534A (zh) 2005-06-08
AR009425A1 (es) 2000-04-12
DE69718506D1 (de) 2003-02-20
CN1237904A (zh) 1999-12-08
ATE230983T1 (de) 2003-02-15
DK0941081T3 (da) 2003-04-22

Similar Documents

Publication Publication Date Title
EE9800219A (xx) Uued 19-nor-pregneeni derivaadid
NO982414D0 (no) Ny kombinasjon
BR9711191A (pt) Composto e uso do mesmo
DE69327474D1 (de) Poröser rotor
DE59705815D1 (de) Verschnapptes mittelrohr
IT1297886B1 (it) Nifedipina per uso topico
ITMI962408A0 (it) Nuovo uso della creatina
DE69702912D1 (de) Uhrwerk
BR7401412U (pt) Estojo de uso pessoal
BR9711681A (pt) Novos m-todos
DE69708782D1 (de) Konstantteiler
IT1289621B1 (it) Impiego di derivati della tetraidroisochinolina
ID18720A (id) Tipe kompresor kedap udara
ITRM940072A0 (it) Uso della ribonucleasi seminali per la terapia antimetastatica
ITMI910328A0 (it) Nuovo uso della benzidamina
IT9019342A1 (it) Nuovo uso della benzidamina
BR9603302A (pt) Politrix múltiplo uso
DE69710504D1 (de) Lampenfassung
SE9601383D0 (sv) New use
ITMI931800A0 (it) Uso della 4 -desossi-4-iododoxorubicina per il trattamento della alamiloidosi
BR7401337U (pt) Escada de múltiplo uso
ITMI921843A0 (it) Nuovo uso della fosfocreatina esogena
IT1307329B1 (it) Uso di derivati di idroisochinolina
ITVI940170A0 (it) Uso alternativo della molecola di o-(b-idrossietil)-rutosidea.
KR970050229U (ko) 국기봉 고정구

Legal Events

Date Code Title Description
0001 Granted